Veraxa Biotech is trading at $1.08, up 10.20%, with no clear catalyst identified. - No new company-specific announcement or reliable catalyst report surfaced; the latest company releases found were dated October 13 and October 7. - The broader U.S. market is lower while the stock is higher. No volume data was provided, and the reason for the rise remains uncertain.